Trials / Active Not Recruiting
Active Not RecruitingNCT06483425
A Biomarker Exploration Study of Precision Treatment in Ovarian Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial aims to investigate the role of biomarkers in guiding precision treatment for ovarian cancer. The study will explore the effectiveness of personalized treatment strategies based on specific biomarkers identified in ovarian cancer patients. By analyzing the correlation between biomarker profiles and treatment outcomes, the trial seeks to optimize treatment decisions and improve overall survival rates in ovarian cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Sequencing of DNA, RNA, and Proteins | Sequencing of DNA, RNA, and Proteins for Tumor, Blood, Ascite, and other samples before and after treatment. |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2024-07-03
- Last updated
- 2024-07-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06483425. Inclusion in this directory is not an endorsement.